Monoclonal Antibody Therapy for Vasculitis

  • C. M. Lockwood
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 336)


This presentation discusses the use of “humanised” monoclonal anti T cell antibody therapy for the treatment of patients with refractory systemic vasculitis.


High Dose Intravenous Immunoglobulin Candida Oesophagitis Antiidiotypic Antibody Mediate Tissue Injury Microscopic Polyarteritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliveira DBG, Lockwood CM and Waldmann H. Monoclonal-antibody therapy in systemic vasculitis. N Eng J Med 323 (1990), pp. 250–254.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • C. M. Lockwood
    • 1
  1. 1.Wellcome Reader in the School of Clinical MedicineUniversity of Cambridge Addenbrooke’s HospitalCambridgeEngland

Personalised recommendations